Significant incidents during X-ray exposures in humans – assessment and findings of the Federal Office for Radiation Protection
RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren · 01.02.2025 · 197 (02) · 154-162
DOI: 10.1055/a-2339-3684 ↗Kurz gefasst
Fachartikel in der Zeitschrift RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, erschienen am 01.02.2025. Verfasst von Katharina Stella Winter und 3 weiteren Autor:innen. Beteiligte Einrichtung: Generic aspects of medical radiation protection, Federal Office for Radiation Protection Neuherberg, Oberschleißheim, Germany. Hauptthemen laut MEDLINE: Radiation Exposure, X-Rays, Radiation Protection, Medical Errors. Die Arbeit nennt 2 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In Germany, significant incidents must be reported to the competent authority since 12/31/2018 (section 108 Radiation Protection Ordinance (StrlSchV)). After assessment and evaluation of the reports, the competent authority submits the relevant information via a web-based reporting system (BeVoMed) to the Federal Office for Radiation Protection (BfS), which publishes the results derived therefrom. The present paper evaluates significant incidents related to X-ray exposures on humans. All reports on incidents in X-ray diagnostics and interventional radiology between 01/2019 and 10/2023, which were completed with detailed information until the reporting day (31/10/2023), were included. The following aspects were statistically evaluated: classification as an incident (section 1 subsection (22) StrlSchV), significance (section 108 StrSchV), classification to Annex 14 StrlSchV, assignment to the forms of care in the German healthcare system, and development of the reporting frequency over time. Furthermore, the content of the reports was systematically evaluated with regard to conspicuous clusters and typical problems. Until the reporting day, 383 reports (355 completed) were received. 252 reports (228 in X-ray diagnostics, 24 in interventional radiology) referred to significant incidents and were included in the detailed evaluation. Reporting frequency increased in X-ray diagnostics, whereas there was no trend in interventional radiology. Most of the significant incidents concerned examinations on an individual person (category I, criterion 2a or category II, criteria 2a and 3a) in the in-patient sector – especially in maximum care hospitals. Frequent errors concerned the inappropriate choice of parameters/protocols or were related to the administration of a contrast agent. Despite the overall positive trend, the establishment of awareness and error culture remains challenging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Generic aspects of medical radiation protection, Federal Office for Radiation Protection Neuherberg, Oberschleißheim, Germany.
ORCID-Profile: Erik Mille
Zitieren
APA
Winter, K. S., Schweden, M., Brix, G., & Mille, E. (2025). Significant incidents during X-ray exposures in humans – assessment and findings of the Federal Office for Radiation Protection. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, 197(02), 154-162. https://doi.org/10.1055/a-2339-3684
Vancouver
Winter KS, Schweden M, Brix G, Mille E. Significant incidents during X-ray exposures in humans – assessment and findings of the Federal Office for Radiation Protection. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 2025;197(02):154-162. doi:10.1055/a-2339-3684
BibTeX
@article{Winter2025,
author = {Winter, Katharina Stella and Schweden, Monika and Brix, Gunnar and Mille, Erik},
title = {Significant incidents during X-ray exposures in humans – assessment and findings of the Federal Office for Radiation Protection},
journal = {RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren},
year = {2025},
volume = {197},
number = {02},
pages = {154--162},
doi = {10.1055/a-2339-3684}
}
EUVIMED